Committee defers action on HB2551 amid concerns about proposed amendment to pharmacy oversight bill Committee members deferred action on House Bill 2551 (Kansas Pharmacy Services Administration Organization Act) after discussion over a conceptual amendment that would remove section 7 and add public-disclosure language; staff and stakeholders will follow up to clarify potential effects on independent pharmacies and PBM communication.

House Bill 2551 is facing delays as lawmakers grapple with potential amendments that could impact communication between independent pharmacies and pharmacy benefit managers.

Learn more here!

#KS #PharmacyIndependence #CitizenPortal #KansasPharmacy #HealthCareAccess #PublicPolicyReview

Kansas pharmacy board urges legislature to adopt USP compounding standards by reference The Kansas State Board of Pharmacy told the House Health and Human Services Committee that adopting United States Pharmacopeia compounding chapters by reference will streamline evolving sterility and compounding rules, with a delayed implementation date and rulemaking authority requested to protect public safety.

The Kansas State Board of Pharmacy is pushing for updated compounding standards to enhance public safety and streamline regulations, citing past tragedies to highlight the urgency.

Learn more here

#KS #CitizenPortal #KansasPharmacy #PublicSafety #HealthcareRegulation #PharmacyStandards

Kansas committee hears divided testimony on bill to let pharmacists initiate limited therapies The House Health and Human Services Committee heard proponent and opponent testimony on House Bill 2,676, which would allow pharmacists to initiate limited therapies (test-and-treat, emergency refills, minor ailments) under a standard-of-care framework. Supporters cited rural access and workforce shortages; medical society raised liability and scope concerns.

Kansas is on the verge of empowering pharmacists to initiate therapy for certain conditions, a move that supporters say could revolutionize healthcare access in rural areas.

Click to read more!

#KS #PharmacyInnovation #HealthcareAccess #CitizenPortal #KansasPharmacy #RuralHealthcare

KBI and pharmacy board press Kansas committee to add fentanyl class and consider scheduling 7‑OH; industry urges carve‑out for natural kratom The Board of Pharmacy and Kansas Bureau of Investigation supported statutory changes to create a fentanyl‑class and add certain substances — including 7‑hydroxymitragynine — to state schedules, while industry and public commenters asked for numeric carve‑outs to avoid criminalizing natural kratom leaf.

Kansas officials are pushing for urgent updates to drug schedules to combat the rising dangers of concentrated kratom derivatives, while industry advocates call for protections for natural kratom leaf.

Click to read more!

#KS #CitizenPortal #KansasPharmacy #SubstanceRegulation #PublicSafety

Kansas Healthcare Leaders Examine 340B Pharmacy Contract Issues and Patient Cost Transparency Officials discuss transparency gaps in Kansas' 340B drug pricing program impacting patient savings.

Kansas lawmakers are tackling the urgent issue of pharmacy deserts and the shocking reality that only 1.4% of savings from the 340B drug pricing program actually benefit consumers.

Get the details!

#KS #CitizenPortal #HealthcareAccess #PatientTransparency #PharmaceuticalReform #KansasPharmacy

Kansas Governor revises pharmacy board appointment terms and residency requirements Kansas alters pharmacy board terms and residency qualifications for board members

Kansas is shaking up pharmacy governance with a new bill that could redefine who leads the State Board of Pharmacy!

Click to read more!

#KS #CivicAccountability #GovernanceReform #PublicHealth #KansasPharmacy #CitizenPortal